Development and application of a Chinese Version of the Language Screening Test (CLAST) in post-stroke patients
Development and application of a Chinese Version of the Language Screening Test (CLAST) in post-stroke patients
复制标题
中文版语言筛查测试(CLAST)的开发及在中风后患者中的应用
DOI:
10.1097/md.0000000000022165
复制
发表时间:
2020-09
期刊:
影响因子:
1.6
通讯作者:
Pan Xiaodong
中科院分区:
文献类型:
--
作者:
Sun Mingyao;Zhan Zhouwei;Chen Bijuan;Xin Jiawei;Chen Xiaochun;Yu Erhan;Lin Lizhen;He Raoli;Pan Xiaodong
Abstract Aphasia shows high incidence in stroke patients and seriously impairs language comprehension, verbal communication, and social activities. Therefore, screening aphasic patients during the acute phase of stroke is crucial for language recovery and rehabilitation. The present study developed a Chinese version of the Language Screening Test (CLAST) and validated it in post-stroke patients. The CLAST was adapted from the Language Screening Test developed by Constance et al to incorporate Chinese cultural and linguistic specificities, and administered to 207 acute stroke patients and 89 stabilized aphasic or non-aphasic patients. Based on the Western Aphasia Battery (WAB) test, its reliability and validity were assessed. A cut-off for the CLAST in Chinese patients was determined by ROC curve analysis. The CLAST comprised 5 subtests and 15 items, including 2 subscores, namely expression (8 points, assessing naming, repetition, and automatic speech) and receptive (7 points maximum, evaluating picture recognition, and verbal instructions) indexes. Analysis of the alternate-form reliability of the questionnaire showed a retest correlation coefficient of 0.945 (P < .001). Intraclass correlation coefficients of three rating teams were >0.98 (P < .001). Internal consistency analysis showed a Cronbach's alpha coefficient of 0.909 (P < .001). The non-aphasia group showed higher scores than the aphasia group (14.2 ± 1.3 vs 10.6 ± 3.8) (P < .01). The questionnaire showed good construct validity by factor analysis. ROC curve analysis showed high sensitivity and specificity for the CLAST, with a cut-off of 13.5. The CLAST is suitable for Chinese post-stroke patients during the acute phase, with high reliability, validity, sensitivity, and specificity.
登录
查看更多内容
影响因子:
6.1
作者:
Wu JB;Lyu ZH;Liu XJ;Li HP;Wang Q
通讯作者:
Wang Q
影响因子:
2.7
作者:
Tijana Simic;E. Rochon;Elissa Greco;R. Martino
通讯作者:
Tijana Simic;E. Rochon;Elissa Greco;R. Martino
影响因子:
4.4
作者:
Charles Ellis;Rose Y. Hardy;R. Lindrooth
通讯作者:
Charles Ellis;Rose Y. Hardy;R. Lindrooth
影响因子:
1.2
作者:
Sabe, L.;Courtis, M. J.;Melian, S.
通讯作者:
Melian, S.
影响因子:
3.5
作者:
Laska, Ann Charlotte;Bartfai, Aniko;Kahan, Thomas
通讯作者:
Kahan, Thomas